m
 
(3 intermediate revisions by 2 users not shown)
Line 1: Line 1:
[[File:LSZ.jpg|350px|right]]
+
[[File:Lsz_blotter.jpg|250px|right]]
  
LSZ, also known as Lysergic acid 2,4-dimethylazetidide, is a hallucinogenic drug and an analogue of LSD developed by the team led by David E. Nichols at Purdue University.  While LSZ has subtly different effects than LSD, it appears to be slightly longer lasting and slightly more potent.
+
'''LSZ''', also known as Lysergic acid 2,4-dimethylazetidide, is a hallucinogenic drug and an analogue of LSD developed by the team led by David E. Nichols at Purdue University.  While LSZ has subtly different effects than LSD, it appears to be slightly longer lasting and slightly more potent.
  
= Dosage =
+
== Dosage ==
  
 
{| class="wikitable"
 
{| class="wikitable"
 
|+ Oral
 
|+ Oral
 +
| Threshold || 80ug
 
|-
 
|-
 
| Light || 100-150μg
 
| Light || 100-150μg
Line 15: Line 16:
 
|}
 
|}
  
= Duration =
+
== Duration ==
  
 
{| class="wikitable"
 
{| class="wikitable"
Line 22: Line 23:
 
| Onset || 90-120 minutes
 
| Onset || 90-120 minutes
 
|-
 
|-
| Total || 7-10 hours
+
| Duration || 7-10 hours
 +
|-
 +
| After-effects || 1-24 hours.
 
|}
 
|}
  
= Effects =
+
== Effects ==
  
 
While LSZ has subtly different effects than LSD, with a slightly shorter duration while also having a longer comeup.
 
While LSZ has subtly different effects than LSD, with a slightly shorter duration while also having a longer comeup.
  
= Harm Reduction =
+
== Harm Reduction ==
  
 
While widespread use of LSZ is relatively new and therefore its full impact is unknown, it is likely that it has a similar safety profile to [[LSD]]. Refer to [[LSD]] and [[Psychedelics#Harm_Reduction|Psychedelic Harm Reduction]] for more information.
 
While widespread use of LSZ is relatively new and therefore its full impact is unknown, it is likely that it has a similar safety profile to [[LSD]]. Refer to [[LSD]] and [[Psychedelics#Harm_Reduction|Psychedelic Harm Reduction]] for more information.
  
= Legal status =
+
== Images ==
 +
<gallery mode="packed-hover">
 +
Image:LSZ.jpg|''LSZ''
 +
</gallery>
  
== America ==
+
== Legal status ==
  
Controlled in the United States via the Federal Analog Act but only if it is intended for human consumption.
+
*USA: Controlled in the United States via the Federal Analog Act but only if it is intended for human consumption.
  
 
[[Category:Drugs]]
 
[[Category:Drugs]]
 
[[Category:Psychedelic]]
 
[[Category:Psychedelic]]
 +
[[Category:Research Chemical]]

Latest revision as of 01:36, 17 October 2016

Lsz blotter.jpg

LSZ, also known as Lysergic acid 2,4-dimethylazetidide, is a hallucinogenic drug and an analogue of LSD developed by the team led by David E. Nichols at Purdue University. While LSZ has subtly different effects than LSD, it appears to be slightly longer lasting and slightly more potent.

Dosage

Oral
Threshold 80ug
Light 100-150μg
Common 150-300μg
Strong 300μg+

Duration

Oral
Onset 90-120 minutes
Duration 7-10 hours
After-effects 1-24 hours.

Effects

While LSZ has subtly different effects than LSD, with a slightly shorter duration while also having a longer comeup.

Harm Reduction

While widespread use of LSZ is relatively new and therefore its full impact is unknown, it is likely that it has a similar safety profile to LSD. Refer to LSD and Psychedelic Harm Reduction for more information.

Images

Legal status

  • USA: Controlled in the United States via the Federal Analog Act but only if it is intended for human consumption.

Top Contributors